In our study, the difference of serum levels of IL-6, IL-15, IL-33, and IL-17 are noted before and after serum biomarkers can reflect systemic inflammatory responses, metabolic changes, and tissue remodeling associated with tendinopathy. The gene discussed is IL6; the disease is disease of the tendon.